Clinical Trial

Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences

Study acronym: STARS
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The main purpose of this interventional study is to examine differences in resting blood pressure control between healthy males and females. The main questions it aims to answer are: 1. Are there sex differences in the communication between the sympathetic nervous system (also known as the "fight or flight" response) and peripheral blood vessels (which influence systemic blood pressure)? 2. What is the role of specific vascular receptors that respond to sympathetic signals, and is it different between males and females? Participants will complete one study visit of approximately 3 hours where they will: * Have a blood sample taken to measure circulating sex hormone and sympathetic transmitters. * Receive very small doses of medications commonly used to adjust blood pressure through an artery in their arm. The effects of these medications will be short-acting and localized to the forearm. * Have their sympathetic nervous activity directly measured through two very small needles (similar to acupuncture needles) in the side of their leg. * Have their blood pressure and heart rate recorded, and forearm blood flow measured using ultrasound.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-08-11; most recent amendment 2026-01-05.
Status change: Suspended → Recruiting 2026-01-05
Status change: Recruiting → Suspended 2024-10-07
Status change: Not Yet Recruiting → Recruiting 2023-10-31
Trial Details
NCT Number NCT05997732
Lead Sponsor University of Alberta
Conditions Vasoconstriction, Vasodilation
Enrollment 30 participants
Start Date 2023-10-31
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-08